Loop delay and gain control methods in closed-loop transmitters and wireless devices
    41.
    发明授权
    Loop delay and gain control methods in closed-loop transmitters and wireless devices 有权
    闭环发射机和无线设备中的环路延迟和增益控制方法

    公开(公告)号:US08000408B2

    公开(公告)日:2011-08-16

    申请号:US12119618

    申请日:2008-05-13

    CPC classification number: H04L27/368 H03G3/3047 H04B17/13 H04B17/14

    Abstract: Embodiments include transmitters, wireless devices, and methods for performing loop delay and gain control. In a transmitter, a gain application element receives and combines digital input samples and a digital gain signal to generate gain-compensated digital samples. A power amplifier receives and amplifies an analog version of the gain-compensated digital samples to generate an antenna output signal. A feedback path generates an analog feedback signal from the antenna output signal, to produce a sequence of digital feedback samples from the analog feedback signal, and generates the digital gain signal from the sequence of digital feedback samples and a loop gain estimate. A loop delay and gain calculator calculates a loop delay estimate from the gain-compensated digital samples and the sequence of digital feedback samples, and calculates the loop gain estimate using the loop delay estimate, the gain-compensated digital samples, and the sequence of digital feedback samples.

    Abstract translation: 实施例包括用于执行环路延迟和增益控制的发射机,无线设备和方法。 在发射机中,增益应用元件接收并组合数字输入采样和数字增益信号以产生增益补偿的数字样本。 功率放大器接收并放大增益补偿数字采样的模拟版本,以产生天线输出信号。 反馈路径从天线输出信号产生模拟反馈信号,以产生来自模拟反馈信号的数字反馈采样序列,并从数字反馈采样序列和环路增益估计中产生数字增益信号。 环路延迟和增益计算器从增益补偿数字样本和数字反馈采样序列中计算出一个环路延迟估计,并使用环路延迟估计,增益补偿数字采样和数字序列序列来计算环路增益估计 反馈样本。

    REAGENT FOR BLOOD ANALYSIS AND METHOD OF USE THEREOF
    44.
    发明申请
    REAGENT FOR BLOOD ANALYSIS AND METHOD OF USE THEREOF 有权
    用于血液分析的试剂及其使用方法

    公开(公告)号:US20100267080A1

    公开(公告)日:2010-10-21

    申请号:US12580474

    申请日:2009-10-16

    Abstract: The present disclosure provides a reagent for blood analysis which may include: (1) a compound having the general formula I as a fluorescent dye, wherein n, X, R1, R2, R3, R4, R5 and Y− are as defined in the specification; (2) a surfactant selected from cationic surfactants, zwitterionic surfactants and anionic surfactants. The present disclosure also provides a method to perform blood analysis including the following steps of: (a) mixing the blood sample with the reagent for blood analysis disclosed to form a cell suspension; (b) detecting the scattered light signals and fluorescence signals from the cells; and (c) differentiating and counting the cells in the blood in terms of the scattered light signals and fluorescence signals.

    Abstract translation: 本公开提供了用于血液分析的试剂,其可以包括:(1)具有通式I的化合物作为荧光染料,其中n,X,R 1,R 2,R 3,R 4,R 5和Y - 如 规范; (2)选自阳离子表面活性剂,两性离子表面活性剂和阴离子表面活性剂的表面活性剂。 本公开还提供了进行血液分析的方法,包括以下步骤:(a)将血液样品与所公开的用于血液分析的试剂混合以形成细胞悬浮液; (b)检测来自细胞的散射光信号和荧光信号; 和(c)根据散射光信号和荧光信号来区分和计数血液中的细胞。

    CYANINE COMPOUNDS AND THEIR USE IN STAINING BIOLOGICAL SAMPLES
    45.
    发明申请
    CYANINE COMPOUNDS AND THEIR USE IN STAINING BIOLOGICAL SAMPLES 有权
    氰胺化合物及其在生物样品中的应用

    公开(公告)号:US20100112584A1

    公开(公告)日:2010-05-06

    申请号:US12607614

    申请日:2009-10-28

    Abstract: Cyanine compounds having the general formula I for staining biological samples, wherein R1, R2, X, Y, A1 and A2 are as defined in the specification. These kinds of compounds may show good light illumination stability, have a maximum absorption peak around 640 nm that may not change as a function of ambient temperature, have rapidly increased fluorescence intensity upon binding to nucleic acids to form compound/nucleic acid complexes, and have a light spectrum in the near-infrared region, thereby effectively reducing interference from background fluorescence and increasing the accuracy of the detection when used as a staining agent for nucleic acids in a flow cytometer. The compounds provided can be used as a staining agent for erythroblasts in the blood.

    Abstract translation: 具有用于染色生物样品的通式I的花青化合物,其中R1,R2,X,Y,A1和A2如说明书中所定义。 这些化合物可能表现出良好的光照度稳定性,在640nm附近具有可能不随环境温度变化的最大吸收峰,结合核酸以迅速增加荧光强度以形成化合物/核酸复合物,并具有 在近红外区域的光谱,从而有效地减少背景荧光的干扰,并且当用作流式细胞仪中核酸的染色剂时,提高检测的准确性。 所提供的化合物可用作血液中成红细胞的染色剂。

    METHOD FOR CREATING INTRACELLULAR ARTIFICIAL NANOSTRUCTURES IN SITU
    46.
    发明申请
    METHOD FOR CREATING INTRACELLULAR ARTIFICIAL NANOSTRUCTURES IN SITU 失效
    方法创建人造纤维人造纳米结构

    公开(公告)号:US20100093084A1

    公开(公告)日:2010-04-15

    申请号:US12194554

    申请日:2008-08-20

    CPC classification number: C12N9/18 B82Y5/00 C12N9/16

    Abstract: A method of creating intracellular artificial nanostructures in situ, which employees a chemical precursor. The precursor does not self-assemble due to the presence of a cleavable motif linked to it. When the precursor comes inside live cells by an uptaking mechanism on the cell membrane, the cleavable motif is then to be removed by an enzymatic action of a first enzyme. Without the cleavable motif, the precursor now engages in a self-assembling process to form nanostructures within the live cells, which may cause formation of a hydrogel. Furthermore, the self-assembling process can be made reversible by employing a second enzyme which puts the cleavable motif back to the precursor, whereby dissolving the nanostructures into solution.

    Abstract translation: 一种原位生成细胞内人造纳米结构的方法,其雇用了化学前体。 由于存在与其连接的可裂解基序,前体不会自组装。 当前体通过细胞膜上的吸收机制进入活细胞时,然后通过第一酶的酶促作用除去可切割基序。 现在,前体不具有自组装过程,以在活细胞内形成纳米结构,这可能导致形成水凝胶。 此外,通过使用将可切割基序重新回到前体的第二种酶,可以使自组装过程可逆,从而将纳米结构溶解到溶液中。

    WHITE BLOOD CELL DIFFERENTIATION REAGENT AND METHOD OF USE THEREOF
    48.
    发明申请
    WHITE BLOOD CELL DIFFERENTIATION REAGENT AND METHOD OF USE THEREOF 有权
    白细胞分化试剂及其使用方法

    公开(公告)号:US20090023129A1

    公开(公告)日:2009-01-22

    申请号:US11967897

    申请日:2007-12-31

    Abstract: The present disclosure provides a white blood cell differentiation reagent comprising a fluorescent dye compound of Formula I, wherein R1, R2, R3, R4, Y− and n are as defined in the specification. The present disclosure also provides a white blood cell detection kit comprising the white blood cell differentiation reagent, and a method of differentiating white blood cells using the white blood cell differentiation reagent.

    Abstract translation: 本公开提供了包含式I的荧光染料化合物的白细胞分化试剂,其中R1,R2,R3,R4,Y-和n如说明书中所定义。 本公开还提供了包含白细胞分化试剂的白细胞检测试剂盒,以及使用白细胞分化试剂来分化白细胞的方法。

    Method and system for booting a network processor
    49.
    发明申请
    Method and system for booting a network processor 有权
    引导网络处理器的方法和系统

    公开(公告)号:US20070174835A1

    公开(公告)日:2007-07-26

    申请号:US11337827

    申请日:2006-01-23

    CPC classification number: G06F9/4416

    Abstract: A network processor system includes a network processor 1, which is provided with a number of interfaces 9, 11, 13, 15, 19, including one or more Ethernet interfaces 9, 11 and a UART interface 19, which can be used to load a software package into the network processor 1. The software package can thus be modified when required, or when the software package previously stored in the network processor system is corrupted. The Ethernet data packets received on the Ethernet interfaces 9, 11 are in a special format, which the network processor 1 can recognize, to distinguish them from conventional Ethernet packets. Thus, the network processor 1 does not have to be programmed to handle the full range conventional Ethernet data packets. The network processor 1 is provided with a second external non-volatile data storage device 7 in the form of a EEPROM memory 7. The EEPROM memory 7 provides a writable extension of the internal ROM memory of the network processor. It can, for example, be used to store the parameters of other components of a network processor system (e.g. a flash memory 5) so that the network processor 1 can be used in conjunction with components of a wide range of types.

    Abstract translation: 网络处理器系统包括网络处理器1,网络处理器1设置有多个接口9,11,13,15,19,包括一个或多个以太网接口9,11和UART接口19,该接口可用于加载 软件包进入网络处理器1。 因此,可以在需要时或当先前存储在网络处理器系统中的软件包损坏时修改软件包。 在以太网接口9,11上接收的以太网数据分组是特殊格式,网络处理器1可以识别,以将其与传统以太网分组区分开。 因此,网络处理器1不必被编程为处理全范围的传统以太网数据分组。 网络处理器1设置有EEPROM存储器7形式的第二外部非易失性数据存储装置7。 EEPROM存储器7提供网络处理器的内部ROM存储器的可写扩展。 例如,其可以用于存储网络处理器系统(例如,闪存5)的其他组件的参数,使得网络处理器1可以与广泛类型的组件结合使用。

    Molecular actuators, and methods of use thereof
    50.
    发明授权
    Molecular actuators, and methods of use thereof 有权
    分子致动器及其使用方法

    公开(公告)号:US07138075B2

    公开(公告)日:2006-11-21

    申请号:US10392354

    申请日:2003-03-19

    CPC classification number: H01B1/127 C08G61/122 H01B1/128

    Abstract: The synthesis of thiophene based conducting polymer molecular actuators, exhibiting electrically triggered molecular conformational transitions is reported. Actuation is believed to be the result of conformational rearrangement of the polymer backbone at the molecular level, not simply ion intercalation in the bulk polymer chain upon electrochemical activation. Molecular actuation results from π—π stacking of thiophene oligomers upon oxidation, producing a reversible molecular displacement that leads to surprising material properties, such as electrically controllable porosity and large strains. The existence of active molecular conformational changes is supported by in situ electrochemical data. Single molecule techniques have been used to characterize the molecular actuators.

    Abstract translation: 报道了噻吩基导电聚合物分子致动器的合成,显示出电触发的分子构象转变。 认为激发是聚合物骨架在分子水平上的构象重排的结果,而不是简单地在电化学活化时主体聚合物链中的离子嵌入。 分子致动由氧化后噻吩低聚物的pi-pi堆叠产生,产生可逆的分子位移,导致令人惊奇的材料性质,例如电可控孔隙率和大应变。 活性分子构象变化的存在由原位电化学数据支持。 已经使用单分子技术来表征分子致动器。

Patent Agency Ranking